SmallCap
CompaniesMapStatistics

테고사이언스(주)

Listed
Venture Certified
Data Quality: 95/10

Basic Information


Listed

Stock Code: 191420

Company Name테고사이언스(주)
English NameTego Science, Inc.
Business Reg. No.3148140292
CEO전세화
Address서울특별시 강서구 마곡중앙8로 93 (마곡동, 테고사이언스)
Industry기초 의약 물질 제조업
Industry Code211
Main Products피부세포치료제 제조,도매,연구개발
Established20010320
Phone02-818-2900
Websitewww.tegoscience.com
Regular Employees42persons
Corp. Reg. No.1601110114126

Investment Metrics


Market Cap
-
Op. Margin
-33%
ROE
6.67%
Debt Ratio
5.69%

Certification Status


Venture Certified

Cert. History
신기술기업(산업지원서비스업)2001-03-30 ~ 2003-03-290111350331085692001-03-30
연구개발기업2003-03-12 ~ 2005-03-110311350212003142001-03-30
연구개발기업2005-03-12 ~ 2007-03-110511350213004722001-03-30
벤처투자유형2007-03-12 ~ 2008-03-11200703001012001-03-30
벤처투자유형2008-03-12 ~ 2009-03-11200803001032001-03-30
벤처투자유형2009-03-12 ~ 2010-03-11200903000492001-03-30
벤처투자유형2010-03-12 ~ 2012-03-11201003000542001-03-30
벤처투자유형2012-03-12 ~ 2014-03-11201203001082001-03-30
벤처투자유형2014-03-12 ~ 2016-03-11201403000902001-03-30
벤처투자유형2016-03-12 ~ 2018-03-11201603000812001-03-30
연구개발유형2018-03-12 ~ 2020-03-11201801026862001-03-30
연구개발유형2020-03-12 ~ 2022-03-11202001026732001-03-30
연구개발유형2022-03-12 ~ 2025-03-11202203310200322001-03-30
연구개발유형2025-03-12 ~ 2028-03-11202503180200212001-03-30

Financial Statements


4-Year Financial Data

Revenue CAGR -6.6%

Item2024202320222021
Revenue

68B

78B

77B

83B

Operating Profit

-22B

-12B

2.1B

-1.0B

Net Profit

33B

-23B

2.6B

0.5B

Total Assets

525B

489B

514B

510B

Total Liabilities

28B

26B

29B

26B

Total Equity

497B

463B

485B

484B

Risk Indicators


1 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
68B

14.6%

vs. 3-Year Avg.: 79B
Operating Profit
-22B

521.6%

vs. 3-Year Avg.: -4B
Op. Margin
-33.0%

620.7%

vs. 3-Year Avg.: -4.6%
Debt Ratio
5.7%

0.5%

vs. 3-Year Avg.: 5.7%
ROE
6.7%

551.8%

vs. 3-Year Avg.: -1.5%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
전세화사내이사총괄 사장
전재욱사내이사전략 기획
이진우사외이사사외 이사
장한규사내이사생산 총괄
정성인감사감사

Employment Status


NPS Subscribers

38persons

CEO전세화
Est. Avg. Annual Salary

4,51110K

(37610K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+0persons

Left (12 mo)

-1persons

Net Change (12 mo)

-1persons

NPS Join Date

2001-03-20

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "서울특별시 강서구 마곡중앙8로",
  "brno": "314814****",
  "cappedWarning": false,
  "companyName": "테고사이언스(주)",
  "estimatedAvgAnnualSalary": 45114816,
  "estimatedAvgMonthlySalary": 3759568,
  "fetchedAt": "2026-03-05T11:07:29.891Z",
  "industryCode": "331100",
  "industryName": "전기식 진단 및 요법 기기 제조업",
  "joinDate": "20010320",
  "last12MonthsHired": 0,
  "last12MonthsLeft": 1,
  "last12MonthsNetChange": -1,
  "leaveDate": null,
  "monthlyPensionAmount": 13572040,
  "monthlyTrend": [
    {
      "lostSubscribers": 1,
      "newSubscribers": 0,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6683143",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 38,
  "turnoverMonths": 1
}

{
  "address": "서울 강서구",
  "ceo_name": "전세화",
  "certificate": [
    {
      "cert_number": "011135033108569",
      "changes": "",
      "disclosure_date": "2001-03-30",
      "first_cert_date": "2001-03-30",
      "no": "1",
      "type": "신기술기업(산업지원서비스업)",
      "valid_period": "2001-03-30 ~ 2003-03-29"
    },
    {
      "cert_number": "031135021200314",
      "changes": "",
      "disclosure_date": "2003-03-12",
      "first_cert_date": "2001-03-30",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2003-03-12 ~ 2005-03-11"
    },
    {
      "cert_number": "051135021300472",
      "changes": "",
      "disclosure_date": "2005-03-12",
      "first_cert_date": "2001-03-30",
      "no": "3",
      "type": "연구개발기업",
      "valid_period": "2005-03-12 ~ 2007-03-11"
    },
    {
      "cert_number": "20070300101",
      "changes": "",
      "disclosure_date": "2007-03-15",
      "first_cert_date": "2001-03-30",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2007-03-12 ~ 2008-03-11"
    },
    {
      "cert_number": "20080300103",
      "changes": "",
      "disclosure_date": "2008-02-28",
      "first_cert_date": "2001-03-30",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2008-03-12 ~ 2009-03-11"
    },
    {
      "cert_number": "20090300049",
      "changes": "",
      "disclosure_date": "2009-02-26",
      "first_cert_date": "2001-03-30",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2009-03-12 ~ 2010-03-11"
    },
    {
      "cert_number": "20100300054",
      "changes": "",
      "disclosure_date": "2010-02-25",
      "first_cert_date": "2001-03-30",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2010-03-12 ~ 2012-03-11"
    },
    {
      "cert_number": "20120300108",
      "changes": "",
      "disclosure_date": "2012-03-29",
      "first_cert_date": "2001-03-30",
      "no": "8",
      "type": "벤처투자유형",
      "valid_period": "2012-03-12 ~ 2014-03-11"
    },
    {
      "cert_number": "20140300090",
      "changes": "",
      "disclosure_date": "2014-03-13",
      "first_cert_date": "2001-03-30",
      "no": "9",
      "type": "벤처투자유형",
      "valid_period": "2014-03-12 ~ 2016-03-11"
    },
    {
      "cert_number": "20160300081",
      "changes": "",
      "disclosure_date": "2016-03-10",
      "first_cert_date": "2001-03-30",
      "no": "10",
      "type": "벤처투자유형",
      "valid_period": "2016-03-12 ~ 2018-03-11"
    },
    {
      "cert_number": "20180102686",
      "changes": "",
      "disclosure_date": "2018-03-16",
      "first_cert_date": "2001-03-30",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2018-03-12 ~ 2020-03-11"
    },
    {
      "cert_number": "20200102673",
      "changes": "",
      "disclosure_date": "2020-03-10",
      "first_cert_date": "2001-03-30",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2020-03-12 ~ 2022-03-11"
    },
    {
      "cert_number": "20220331020032",
      "changes": "",
      "disclosure_date": "2022-03-31",
      "first_cert_date": "2001-03-30",
      "no": "13",
      "type": "연구개발유형",
      "valid_period": "2022-03-12 ~ 2025-03-11"
    },
    {
      "cert_number": "20250318020021",
      "changes": "",
      "disclosure_date": "2025-03-18",
      "first_cert_date": "2001-03-30",
      "no": "14",
      "type": "연구개발유형",
      "valid_period": "2025-03-12 ~ 2028-03-11"
    }
  ],
  "company_name": "테고사이언스주식회사",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 4054417000,
      "cost_of_sales": 1953512000,
      "current_assets": 27165789000,
      "current_liabilities": 1205230000,
      "gross_profit": 5061108000,
      "net_income": 279680000,
      "net_income_bs": 334094000,
      "non_current_assets": 23894653000,
      "non_current_liabilities": 286622000,
      "non_operating_expenses": 590037000,
      "non_operating_income": 600467000,
      "operating_profit": 269250000,
      "revenue": 7014619000,
      "sga_expenses": 4791858000,
      "total_assets": 51060442000,
      "total_equity": 49568590000,
      "total_liabilities": 1491852000
    },
    "2023": {
      "capital_stock": 4054417000,
      "cost_of_sales": 2335430000,
      "current_assets": 28008790000,
      "current_liabilities": 654671000,
      "gross_profit": 4888890000,
      "net_income": -2370752000,
      "net_income_bs": -2151010000,
      "non_current_assets": 20667128000,
      "non_current_liabilities": 414027000,
      "non_operating_expenses": 2534988000,
      "non_operating_income": 1205871000,
      "operating_profit": -1041635000,
      "revenue": 7224320000,
      "sga_expenses": 5930525000,
      "total_assets": 48675918000,
      "total_equity": 47607220000,
      "total_liabilities": 1068698000
    }
  },
  "industry": "기초 의약 물질 제조업",
  "investment": [
    {
      "amount": "187,747,000",
      "changes": "187,747,000",
      "date": "2006-02-27"
    }
  ],
  "main_products": "피부세포치료제 제조,도매,연구개발",
  "phone": "02-818-****",
  "years": [
    2023,
    2022
  ]
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsDART
Collected
Investment MetricsDART
Collected
OfficersDART
Collected
EmploymentDART
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
DART Financial2026-02-27
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
Employment Insurance2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected